Embryonal Rhabdomyosarcoma

• CLINICAL_TRIALS research · 2026-02-24
  Clinical Trial Update: Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma [Phase 3]

  Phase 3 trial evaluating chemotherapy for newly diagnosed very low-risk and low-risk fusion-negative rhabdomyosarcoma; currently recruiting.

• CLINICAL_TRIALS research · 2026-02-17
  Clinical Trial Update: A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma [Phase 3]

  Phase 3 study by the Children's Oncology Group comparing early use of vinorelbine and maintenance therapy for high-risk rhabdomyosarcoma is …

• CLINICAL_TRIALS research · 2026-02-06
  Clinical Trial Update: Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma

  This clinical trial update investigates genetic mutational analysis using saliva or buccal mucosa samples from patients with embryonal rhabd…

• CLINICAL_TRIALS research · 2024-11-01
  Clinical Trial Update: Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas [Phase 3]

  A Phase 3 clinical trial registry entry describing a chemo-immunotherapy study in patients under 18 with bone sarcoma and soft tissue sarcom…

• CLINICAL_TRIALS trial_result · 2024-10-01
  Clinical Trial Update: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma [Phase 3]

  Phase 3 trial evaluating adding temsirolimus to combination chemotherapy for intermediate-risk rhabdomyosarcoma; results posted in 2024 and …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-10-01
  Clinical Trial Update: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma [Phase 3]

  Phase 3 trial examining combination chemotherapy with or without temsirolimus in intermediate-risk rhabdomyosarcoma; active/not recruiting w…

• CLINICAL_TRIALS trial_result · 2022-04-14
  Clinical Trial Update: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma [Phase 1, Phase 2]

  A phase 1/2 trial evaluating ganitumab (IGF-1R antibody) with dasatinib (SFK inhibitor) in embryonal and alveolar rhabdomyosarcoma was termi…

• CLINICAL_TRIALS trial_result · 2017-07-28
  Clinical Trial Update: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma [Phase 2]

  A Phase 2 trial evaluated temozolomide in combination with cixutumumab and chemotherapy for metastatic rhabdomyosarcoma; the study has compl…

• CLINICAL_TRIALS research · 2016-07-14
  Clinical Trial Update: Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma

  This ClinicalTrials.gov update describes a study investigating mechanisms of radiation therapy resistance in rhabdomyosarcoma samples from p…

• CLINICAL_TRIALS trial_result · 2016-05-19
  Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma

  The Children's Oncology Group completed a trial update analyzing biomarkers in tumor tissue from younger patients with rhabdomyosarcoma, inc…

• CLINICAL_TRIALS research · 2016-05-18
  Clinical Trial Update: Biomarkers in Patients With Advanced Rhabdomyosarcoma

  This completed clinical trial explored biomarkers in patients with advanced rhabdomyosarcoma.

• CLINICAL_TRIALS trial_result · 2016-05-18
  Clinical Trial Update: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma

  A clinical trial examining protein expression in tissue samples from younger patients with alveolar rhabdomyosarcoma and embryonal rhabdomyo…

• CLINICAL_TRIALS trial_result · 2013-08-12
  Clinical Trial Update: Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma [Phase 2]

  Phase 2 clinical trial evaluating Vincristine, Dactinomycin, and Cyclophosphamide for embryonal rhabdomyosarcoma.

• CLINICAL_TRIALS research · 2013-08-12
  Clinical Trial Update: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma [Phase 2]

  This Phase 2 trial investigates a chemotherapy regimen of vincristine, dactinomycin, and cyclophosphamide with optional radiation therapy fo…

• CLINICAL_TRIALS trial_result · 2013-01-17
  Clinical Trial Update: Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma [Phase 2]

  This ClinicalTrials.gov update describes a Phase 2 pediatric trial comparing chemotherapy regimens for relapsed or progressive rhabdomyosarc…